ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,205Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 2429

$1.53M Total Retail Price of All Prescriptions

Rank: 10 out of 2429

697 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 697 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

29% of this provider’s 697 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 19,349 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
HYDROCODONE-ACETAMINOPHEN 1,077 667 S3 1 6
LISINOPRIL 1,016 765 2 2
SIMVASTATIN 868 576 3 1
LEVOTHYROXINE SODIUM 819 691 4 3
FUROSEMIDE 792 589 5 5
POTASSIUM CHLORIDE 646 509 6 14
WARFARIN SODIUM 573 496 7 11
CITALOPRAM HBR 557 438 8 19
OMEPRAZOLE 551 351 9 7
PRAVASTATIN SODIUM 536 438 10 16
METFORMIN HCL 516 307 11 8
AMLODIPINE BESYLATE 507 436 12 4
METOPROLOL SUCCINATE 462 385 13 12
METOPROLOL TARTRATE 450 363 14 9
CLOPIDOGREL 418 343 15 31
ATENOLOL 354 267 16 15
GABAPENTIN 311 183 17 18
FAMOTIDINE 277 176 18 42
RISPERIDONE 276 116 19 52
CYMBALTA 272 153 20 58
ZOLPIDEM TARTRATE 265 154 21 28
ALLOPURINOL 258 218 22 33
NAMENDA 256 254 23 35
ATORVASTATIN CALCIUM 253 212 24 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 253 156 24 27
CRESTOR 247 193 26 25
PLAVIX 245 205 27 44
HYDROCHLOROTHIAZIDE 235 188 28 10
RANITIDINE HCL 228 139 29 24
DONEPEZIL HCL 222 183 30 26
EXELON 222 222 30 132
ESCITALOPRAM OXALATE 205 159 32 74
CARVEDILOL 204 146 33 21
PANTOPRAZOLE SODIUM 200 146 34 34
GLYBURIDE 194 125 R 35 64
TERAZOSIN HCL 193 135 36 124
SPIRIVA 188 140 37 54
SERTRALINE HCL 185 114 38 23
DIOVAN 182 133 39 36
LANTUS 178 111 40 45
ISOSORBIDE MONONITRATE ER 169 162 41 55
LEVOFLOXACIN 167 114 42 87
FENTANYL 162 98 S2 43 59
PROAIR HFA 160 121 44 41
ALENDRONATE SODIUM 157 118 45 20
NIASPAN 153 85 46 113
TRAMADOL HCL 149 103 47 17
VENLAFAXINE HCL ER 145 87 48 98
SUCRALFATE 142 104 49 150
ROPINIROLE HCL 140 84 50 92
KLOR-CON M20 136 85 51 60
DICLOFENAC SODIUM 133 98 52 103
PREDNISONE 128 96 53 38
FLUTICASONE PROPIONATE 126 72 54 39
CARISOPRODOL 122 41 R 55 174
BYSTOLIC 119 94 56 138
LYRICA 117 78 57 95
TRAZODONE HCL 116 65 58 50
NEXIUM 111 65 59 37
LOSARTAN POTASSIUM 108 59 60 22
ABILIFY 108 62 60 121
DIVALPROEX SODIUM 107 13 62 78
ADVAIR DISKUS 107 62 62 49
FLUOXETINE HCL 104 78 64 61
TAMSULOSIN HCL 101 100 65 29
DIGOXIN 101 90 65 43
SYMBICORT 96 30 67 135
CEFUROXIME 94 71 68 179
DILTIAZEM 24HR ER 93 81 69 137
ENDOCET 93 39 S2 69 345
FINASTERIDE 90 75 71 126
SPIRONOLACTONE 89 82 72 62
POLYETHYLENE GLYCOL 3350 87 79 73 56
DILTIAZEM 24HR CD 86 73 74 94
LACTULOSE 84 78 75 142
MELOXICAM 82 52 76 40
NABUMETONE 82 41 76 96
SINGULAIR 81 27 78 86
NYSTATIN 80 52 79 167
PHENYTOIN SODIUM EXTENDED 79 33 80 108
OXYCONTIN 78 0 S2 81 212
INSULIN SYRINGE 78 39 81 90
BUSPIRONE HCL 76 39 83 160
PHENYTOIN 76 21 83 236
OXYBUTYNIN CHLORIDE ER 75 59 85 79
AMITRIPTYLINE HCL 74 41 R 86 71
BENICAR 74 74 86 164
BENAZEPRIL HCL 73 72 88 80
LEXAPRO 73 66 88 203
ACTONEL 72 66 90 188
HYDRALAZINE HCL 72 64 90 81
SULFAMETHOXAZOLE-TRIMETHOPRIM 72 52 90 102
NITROFURANTOIN MONO-MACRO 69 57 93 219
LEVEMIR 68 55 94 193
PROPRANOLOL HCL 67 60 95 119
MIRTAZAPINE 67 67 95 63
PAROXETINE HCL 66 47 97 67
NAPROXEN 66 27 97 75
FLUCONAZOLE 64 37 99 217
VENLAFAXINE HCL 63 28 100 279
LOVASTATIN 63 31 100 30
GEMFIBROZIL 62 27 102 107
TRICOR 61 29 103 125
CIPROFLOXACIN HCL 60 51 104 84
LOSARTAN-HYDROCHLOROTHIAZIDE 60 56 104 73
QUETIAPINE FUMARATE 58 53 106 77
ENABLEX 58 39 106 229
METHYLPREDNISOLONE 58 36 106 144
GLIPIZIDE 56 31 109 47
PRADAXA 55 52 110 256
VENTOLIN HFA 55 21 110 106
NIFEDIPINE ER 55 48 110 76
CLONIDINE HCL 55 22 110 68
VESICARE 55 34 110 158
TRIAMCINOLONE ACETONIDE 54 28 115 99
TOPIRAMATE 54 0 115 136
AMIODARONE HCL 54 51 115 210
NYSTOP 53 43 118 228
TRILIPIX 53 21 118 170
DIOVAN HCT 52 48 120 83
COMBIVENT 52 45 120 154
SYNTHROID 50 44 122 93
JANUVIA 50 36 122 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 3, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.